Filters
Knowledge Publications
""

IP Australia called for public feedback on proposals to reform the Australian designs system in late 2019. Assisted by the feedback received, IP Australia…

Expertise Area

The COVID-19 pandemic has dramatically increased the demands on vital medical devices, pharmaceuticals and related technologies. These include preventative…

As the world fights the COVID-19 pandemic IP Offices around the world, like IP Australia and the Intellectual Property Office of New Zealand (IPONZ), are…

We are undoubtedly living in challenging economic times; as a result, many businesses are looking for ways to improve their balance sheets and cashflow…

You may have a great business idea, but that doesn’t mean you can obtain a patent to protect and monopolise it.

As the COVID-19 pandemic escalates globally, businesses are facing another kind of outbreak – a rise in COVID-19 related cyber security attacks. In this…
In the race to find both a vaccine and cure for COVID-19, the tension between monopoly rights and public access to crucial medicines, diagnostics and medical…

Data is increasingly being understood as a valuable asset.  

For businesses, it is now clear that having a thorough understanding of their data…

Described by Murphy J as “ill advised proceedings…with no clear winner”, the decision that iconic Australian swimwear brand Triangl did not infringe…

Expertise Area

A recent decision by Justice Beach of the Federal Court of Australia (“Federal Court”) in SNF (Australia) Pty Ltd v BASF Australia Ltd (2019) 140 IPR 276 (“…

Expertise Area

G+T partner, Chris Williams, and former partner and consultant to the firm, Peter Leonard, recently contributed the Australian chapter to the Global Law and…

Expertise Area